Thermo Fisher partners with OpenAI to accelerate drug development, enhance clinical trials, and optimize biopharma operations ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...
Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid leukemia. This form of cancer was once regarded as very difficult to combat, ...
NZ drug maker’s expansion plans are no Aft-erthought Cann Group returns to profits – in August at least Veteran Sonic Healthcare chief calls it a day Kiwi drug maker and distributor AFT ...
Institute of High-Quality Education Development (Key Cultivation Research Institute Centre of Philosophy and Social Sciences of Zhejiang Province), Zhejiang Normal University, Jinhua, Zhejiang 321004, ...
Collaboration combines Prellis' first-of-a-kind Biological AI – a rapid organoid and AI platform - with Lilly's world-class expertise in research, development and commercialization to develop ...
Novo Nordisk and Eli Lilly have established a commanding lead in obesity with their drugs Wegovy and Zepbound, with each recording sales of nearly $6 billion through the first six months of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback